EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Retrospective review of morbidity and mortality of Sumatran tigers (Panthera tigris sumatrae ) in European zoological institutions between 2011 and 2025

Harriet Woodhall, Mark F. Stidworthy, Kyle McCreesh, Teague Stubbington, Amanda Guthrie, Simon Spiro

Journal of Zoo and Wildlife Medicine · 2026-10-21 · 57 (4) · 768-777

DOI: 10.1638/2026-0053 ↗
AbstractBibliografische Angaben

Abstract

Sumatran tigers (Panthera tigris sumatrae) are listed as critically endangered by the International Union for Conservation of Nature, and the maintenance of self-sustaining insurance populations is important for the conservation of this species. The objective of this retrospective study was to review and analyze causes of morbidity and mortality in Sumatran tigers housed in European zoological facilities between 2011 and 2025. Postmortem reports from 84 tigers were provided from 37 European Association of Zoos and Aquaria (EAZA) ex situ program (EEP) member institutions. Morbidities and mortalities across different age groups were identified and categorized by organ system and etiology. Non-infectious diseases were the most common causes of death across all age groups (61.9%). Degenerative (31.3%) conditions were common contributors to mortality in adult and geriatric tigers (> 10 years old). Renal disease was identified in 64.3% of the population across most age categories, with a particular prevalence in adult and geriatric tigers. Trauma and parental neglect were common in neonates. Sex had no influence over causes of death. This review emphasizes the importance of standardization in postmortem reports, improved record keeping, active surveillance of births, and close monitoring of long-term degenerative conditions.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →